PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas
- PMID: 9484844
- DOI: 10.1038/sj.onc.1201689
PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas
Abstract
A novel tumor suppressor, PTEN/MMAC1, was recently found on chromosome 10q23 and mutations of this gene were described in about 20% of primary glioblastomas (GBM) and 60% of GBM cell lines. To define further the relevance of PTEN/MMAC1 mutations in GBM we investigated by SSCP analysis its coding sequence in 44 gliomas, including 41 GBM, and in 21 short-term cultures (15 GBM and six malignant astrocytomas). Loss of heterozygosity (LOH) at 10q23 was present in at least one marker in the vicinity of the PTEN/MMAC1 locus in 59% of the informative GBM (primary tumors and cell cultures). SSCP variant bands were found in seven primary GBM (17%) and in one short-term GBM culture and sequence analysis confirmed the presence of somatic mutations in all these cases (five missense, one splicing mutation and two small deletions). These data indicate that PTEN/MMAC1 is inactivated in a subset of GBM and suggest that the high mutation frequency previously found in GBM established cell lines reflects culture condition artifacts rather than the true mutation frequency in vivo. Other suppressors, located on chromosome 10q, may also have a critical role in glioma tumorigenesis.
Similar articles
-
Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.Cancer Res. 1998 Jan 1;58(1):29-33. Cancer Res. 1998. PMID: 9426052
-
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.Cancer Res. 1997 Dec 1;57(23):5221-5. Cancer Res. 1997. PMID: 9393738
-
Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.Oncogene. 1998 Jun 25;16(25):3331-5. doi: 10.1038/sj.onc.1201832. Oncogene. 1998. PMID: 9681833
-
Molecular pathogenesis of malignant gliomas.Curr Opin Oncol. 1999 May;11(3):162-7. doi: 10.1097/00001622-199905000-00004. Curr Opin Oncol. 1999. PMID: 10328589 Review.
-
[Genes implicated in glial tumors].Morphologie. 2000 Jun;84(265):51-5. Morphologie. 2000. PMID: 11048299 Review. French.
Cited by
-
Targeting the PI3-kinase/Akt/mTOR signaling pathway.Surg Oncol Clin N Am. 2013 Oct;22(4):641-64. doi: 10.1016/j.soc.2013.06.008. Epub 2013 Aug 6. Surg Oncol Clin N Am. 2013. PMID: 24012393 Free PMC article. Review.
-
Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.Brain Pathol. 1999 Jul;9(3):469-79. doi: 10.1111/j.1750-3639.1999.tb00536.x. Brain Pathol. 1999. PMID: 10416987 Free PMC article.
-
Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma.Mol Cancer. 2004 Oct 6;3:25. doi: 10.1186/1476-4598-3-25. Mol Cancer. 2004. PMID: 15469606 Free PMC article.
-
Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.Br J Cancer. 2001 Mar 23;84(6):748-53. doi: 10.1054/bjoc.2000.1660. Br J Cancer. 2001. PMID: 11259087 Free PMC article.
-
Molecular pathogenesis of astrocytic tumours.J Neurooncol. 2004 Nov;70(2):137-60. doi: 10.1007/s11060-004-2747-2. J Neurooncol. 2004. PMID: 15674475 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials